- Home
- CIK vs ANIX Comparison
CIK vs ANIX Comparison
Compare CIK & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIK | ANIX |
|---|---|---|
| Founded | 1987 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.7M | 135.3M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | CIK | ANIX |
|---|---|---|
| Price | $2.82 | $4.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 115.4K | ★ 178.3K |
| Earning Date | 01-01-0001 | 01-09-2026 |
| Dividend Yield | ★ 9.03% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.50 | $2.07 |
| 52 Week High | $3.19 | $4.98 |
Technical Indicators
Market Signals| Indicator | CIK | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 59.46 |
| Support Level | $2.81 | $4.20 |
| Resistance Level | $2.85 | $4.91 |
| Average True Range (ATR) | 0.03 | 0.26 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 68.18 | 80.23 |
Price Performance
Historical ComparisonAbout CIK Credit Suisse Asset Management Income Fund Inc.
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.